Sage Journals: Discover world-class research

Abstract

Protegrins, small peptides (1900 to 2160 daltons) isolated from porcine leukocytes, are bactericidal against a broad range of medical pathogens in vitro under conditions which reflect the extracellular milieu. The purpose of this study was to determine whether Gram-negative, facultative periodontal pathogens were sensitive to the protegrins. Synthetic L- and D-enantiomers of protegrin 1 (PG-1 and D-PG-1, respectively), and L-enantiomers of protegrins 2, 3, and 5 (PG-2, PG-3, and PG-5) were tested against Actinobacillus actinomycetemcomitans (three strains) and Capnocytophaga spp. (three strains). Strains of both A. actinomycetemcomitans and Capnocytophaga spp. were sensitive to PG-1, and exhibited ED99 (dose at which 99% killing was observed after 1 hr at 37°C) of 0.5 to 3 ug/mL and 4 to 19 ug/mL, respectively. The D-form and the L-form were equally effective. Serum (above 5% v/v) inhibited the bactericidal effects of 10 ug/mL PG-1, but the inhibitory effect was overcome by concentrations of PG-1 at 100 ug/mL. Different patterns of sensitivity were observed when the effects of PG-1, D-PG-1, PG-2, PG-3, and PG-5 were compared against A. actinomycetemcomitans and the Capnocytophaga. We conclude that protegrins may be useful antimicrobial agents in therapy against periodontal infections.

Keywords

Protegrin bactericidal antibiotic peptides periodontal oral.

Get full access to this article

View all access options for this article.

References

Abbott BH , Caffesse RG (1977). Crevicular fluid: origin, composition, methods of collection, and clinical significance. J West Soc Periodontol 25:164-178.

ASM Task Force on Antibiotic Resistance (1995 ). Report of the ASM Task Force on Antibiotic Resistance.

Washington, DC : American Society for Microbiology. Fahrner RL , Dieckmann T. , Harwig Ssl , Lehrer RI , Eisenberg D. , Feigon J. (1996). Solution structure of protegrin-1, a broad-spectrum antimicrobial peptide from porcine leukocytes. Chem Biol 3:543-550.

Forlenza SW , Newman MG , Lipsey AI , Siegel SE , Blachman U. (1980). Capnocytophaga sepsis: newly recognised clinical entity in granulocytopenic patients. Lancet i:567-568. Gabay JE (1994). Ubiquitous natural antibiotics . Science 264:373-374.

Harwig SS , Swiderek KM , Lee TD , Lehrer RI (1995). Determination of disulphide bridges in PG-2, an antimicrobial peptide from porcine leukocytes. J Eur Peptide Sci 3:207-215.

Hill CP , Yee J. , Selsted ME , Eisenberg D. (1991). Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. Science 251:1481-1485.

Kalmar JR , Arnold RR , van Dyke TE (1987). Direct interaction of Actinobacillus actinomycetemcomitans with normal and defective (LJP) neutrophils. J Periodont Res 22:179-181.

Kokryakov VN , Harwig SS , Panyutich EA , Shevchenko AA , Aleshina GM , Shamova OV , et al. (1993). Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins. FEBS Lett 327:231-236.

Lehrer RI , Barton A. , Daher KA , Harwig SS , Ganz T. , Selsted ME (1989). Interaction of human defensins with Escherichia coli: mechanism of bactericidal activity. J Clin Invest 84:553-561.

10.

Mandel ID , Wotman S. (1976). The salivary secretions in health and disease . Oral Sci Rev 8:25-47.

11.

Masuda K. , Ohta M. , Ito M. , Ohsuka S. , Kaneda T. , Kato N. ( 1994). Bactericidal action of tachyplesin I against oral streptococci . Oral Microbiol Immunol 9:77-80.

12.

Miyasaki KT , Bodeau AL (1991). In vitro killing of oral Capnocytophaga by granule fractions of human neutrophils is associated with cathepsin G activity. J Clin Invest 87:1585-1593.

13.

Miyasaki KT , Bodeau AL , Ganz T. , Selsted ME , Lehrer RI (1990). In vitro sensitivity of oral, Gram-negative, facultative bacteria to the bactericidal activity of human neutrophil defensins. Infect Immun 58:3934-3940. Miyasaki KT , Bodeau AL , Pohl J. , Shafer WM (1993). Bactericidal activities of synthetic human leukocyte cathepsin G-derived antibiotic peptides and congeners against Actinobacillus actinomycetemcomitans and Capnocytophaga sputigena. Antimicrob Agents Chemother 37:2710-2715.

14.

Page RC ( 1992). Host response tests for diagnosing periodontal diseases . J Periodontol 63:356-366.

15.

Qu XD , Harwig SS , Oren AM , Shafer WM , Lehrer RI (1996). Susceptibility of Neisseria gonorrhoeae to protegrins . Infect Immun 64:1240-1245.

16.

Ritonja A. , Kopitar M. , Jerala R. , Turk V. ( 1989). Primary structure of a new cysteine proteinase inhibitor from pig leucocytes. FEBS Lett 255:211-214.

17.

Tamamura H. , Murakami T. , Horiuchi S. , Sugihara K. , Otaka A. , Takada W. , et al. (1995). Synthesis of protegrin-related

18.

peptides and their antibacterial and anti-human immunodeficiency virus activity . Chem Pharm Bull 43:853-858. Verbanac D. , Zanetti M. , Romeo D. (1993). Chemotactic and protease-inhibiting activities of antibiotic peptide precursors . FEBS Lett 317:255-258.

19.

Wade D. , Boman A. , Wahlin B. , Drain CM , Andreu D. , Boman HG , et al. (1990). All-D amino acid-containing channel-

20.

Zhao C. , Liu L. , Lehrer RI (1994). Identification of a new member of the protegrin family by cDNA cloning. FEBS Lett 346:285-288.

21.

Zhao C. , Ganz T. , Lehrer RI (1995). The structure of porcine protegrin genes. FEBS Lett 368:197-202.

Sensitivity of Periodontal Pathogens to the Bactericidal Activity of Synthetic Protegrins,Antibiotic Peptides Derived from Porcine Leukocytes

Abstract

Keywords

Get full access to this article

References